Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of utidelone plus capecitabine for metastatic breast cancer in China.
Liao, Mengting; Jiang, Qin; Hu, Huabin; Han, Jiaqi; She, Longjiang; Yao, Linli; Ding, Dong; Huang, Jin.
Afiliação
  • Liao M; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
  • Jiang Q; b Department of Respiratory , The Seventh Affiliated Hospital of Sun Yat-sen University , Shenzhen , PR China.
  • Hu H; c Department of Medical Oncology , The Sixth Affiliated Hospital of Sun Yat-Sen University , Guangzhou , PR China.
  • Han J; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
  • She L; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
  • Yao L; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
  • Ding D; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
  • Huang J; a Departmen of Oncology , Xiangya Hospital, Central South University , Changsha , PR China.
J Med Econ ; 22(6): 584-592, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30808230

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Epotilonas / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Epotilonas / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Female / Humans País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article